Bone Biologics Patents Bone Regeneration Technology
27 Jun 2025 //
BUSINESSWIRE
Bone Biologics Regains Nasdaq Listing Compliance
26 Jun 2025 //
BUSINESSWIRE
Bone Biologics Appoints Robert E. Gagnon to Board of Directors
11 Jan 2024 //
BUSINESSWIRE
Bone Biologics Announces 1-for-8 Reverse Stock Split
18 Dec 2023 //
BUSINESSWIRE
Bone Biologics Engages Avania for NB1 Clinical Trial
27 Jan 2023 //
CONTRACT PHARMA
Bone Biologics CEO Issues Letter to Stockholders
25 Oct 2022 //
BUSINESSWIRE
Bone Biologics Announces Closing of $5,100,000 Underwritten Public Offering
12 Oct 2022 //
BUSINESSWIRE
Bone Biologics announces ~$8M stock offering, reverse stock split
13 Oct 2021 //
SEEKINGALPHA